Kalfeist, L.; Galland, L.; Ledys, F.; Ghiringhelli, F.; Limagne, E.; Ladoire, S.
Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells 2022, 11, 770.
https://doi.org/10.3390/cells11050770
AMA Style
Kalfeist L, Galland L, Ledys F, Ghiringhelli F, Limagne E, Ladoire S.
Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells. 2022; 11(5):770.
https://doi.org/10.3390/cells11050770
Chicago/Turabian Style
Kalfeist, Laura, Loïck Galland, Fanny Ledys, François Ghiringhelli, Emeric Limagne, and Sylvain Ladoire.
2022. "Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era" Cells 11, no. 5: 770.
https://doi.org/10.3390/cells11050770
APA Style
Kalfeist, L., Galland, L., Ledys, F., Ghiringhelli, F., Limagne, E., & Ladoire, S.
(2022). Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era. Cells, 11(5), 770.
https://doi.org/10.3390/cells11050770